Worcester, Massachusetts (PRWEB) June 07, 2012
Blue Sky BioServices, the leading Contract Research Organization (CRO) for “Gene through Screen” services, announced today that they will be participating in the 2012 BIO International Convention’s One-on-One Partnering Meetings. All meetings will be held June 18-21 in Boston, MA at the Boston Convention & Exhibition Center. The Company will also be exhibiting at the event.
“Blue Sky is now in its 10th year of operation and our industry leadership is a direct result of our investments in our scientific team and our value-added technologies,” says Paul Wengender, founder and CEO, Blue Sky Biotech. “Participating in the One-on-One Partnering will provide our partners with the opportunity to meet with these leaders and learn more about options to enhance the productivity of their biological research efforts.”
Blue Sky BioServices partners with life science companies to increase workflow productivity through superior speed, quality and trusted leadership. Blue Sky has invested over $9 million in their technology platforms to provide a core suite of services including vector/gene construction, recombinant protein expression, laboratory-scale fermentation (scale-up bioprocessing), protein purification, assay development and screening.
Individuals and organizations attending BIO 2012 can schedule meetings with Blue Sky by visiting (registration required): http://oneononepartnering.bio.org/BusinessForum2012
Representatives available to meet include:
Blue Sky will be hosting meetings:
For companies or individuals not participating in partnering meetings, Blue Sky will be exhibiting in booth number #2847 located in Hall A – Contract Services Zone (http://www.mapyourshow.com/shows/index.cfm?show_id=bio12).
About Blue Sky BioServices
Blue Sky BioServices (http://www.blueskybiotech.com) is the leading Contract Research Organization (CRO) providing Gene Through Screen services in the Biotechnology R&D market. Our clients elevate the quality and speed of their research by enlisting Blue Sky’s premium services such as vector/gene construction, recombinant protein expression, laboratory-scale fermentation (scale-up bioprocessing), protein purification, assay development and assay execution (screening).
Blue Sky is not your average CRO and invests heavily in experienced people, leading edge technology, and state-of-the-art laboratory facilities. This investment in service platforms and scientists sets Blue Sky apart from other CROs and transforms the company into a center of excellence with unmatched quality and turnaround times.
Our suite of services is our client’s Pathway to Productivity. We are motivated by our ability to impact the overall efficiency of the drug discovery process and thus contributing to a longer, healthier lifespan for human beings.